Prices re-read October 15, 2026Methodology v4.1How we score →
Compare Providers
Home / Advertising policy

Released: ·Last reviewed: ·Methodology v4.1

Researched By
Medical Researcher · Western University of Health Sciences
Last medically reviewed: August 4, 2026 · This page is informational and does not constitute medical advice.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Advertising policy

What advertising we accept, how it is labeled, and its firewall from editorial.

What we accept

We may accept advertising and affiliate relationships. We do not accept payment to change a score, rank or inclusion.

Labeling

Advertising and sponsored content are clearly labeled and visually separated from editorial content, and never mixed into rankings.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.